Close

Ocugen, Inc. (OCGN) PT Lowered to $4.50 at Chardan Capital Markets

June 10, 2021 9:48 AM EDT
Get Alerts OCGN Hot Sheet
Price: $2.84 +5.97%

Rating Summary:
    3 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 40 | New: 22
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Chardan Capital Markets analyst Keay Nakae lowered the price target on Ocugen, Inc. (NASDAQ: OCGN) to $4.50 (from $8.00) while maintaining a Neutral rating after the company announced that it will no longer seek to secure FDA Emergency Use Authorization (EUA) for Bharat Biotech’s Covid-19 vaccine candidate, COVAXIN.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Chardan Capital Markets, FDA